|
Delayed
Nasdaq
16:45:47 14/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.975 USD | -1.12% |
|
-2.81% | -61.24% |
| 08-11 | Intensity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | Intensity Therapeutics, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INTS | Delayed | |
CBOE
| INTS | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 4.895 | 6.49 | 7.95 |
| Spread/Res. | -18.79% | -38.75% | -50.00% |
| Spread/Supp. | +0.38% | +9.81% | +9.81% |
| Support | 3.96 | 3.62 | 3.62 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- INTS Stock
- Charts Intensity Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
